MyFinsight
Home
About
Contact
rytm: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, RYTM has $506,874K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
506,874
372,733
Total liabilities, convertible preferred stock and stockholders' equity
506,874
372,733
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$23,609K
Inventory
$22,107K
Accounts receivable, net
$33,034K
Short-term investments
$363,974K
Cash and cash
equivalents
$52,078K
Other long-term
assets
$2,473K
Restricted cash
$671K
Intangible assets, net
$5,533K
Right-of-use asset
$3,158K
Property and equipment,
net
$237K
Total current assets
$494,802K
Total assets
$506,874K
Total liabilities,
convertible preferred stock...
$506,874K
Total stockholders'
equity
$148,817K
Series a convertible
preferred stock, 0.001 par...
$146,866K
Total liabilities
$211,191K
Accumulated deficit
-$1,304,372K
Accumulated other
comprehensive (loss)
-$926K
Additional paid-in capital
$1,454,048K
Lease liability,
non-current
$3,515K
Deferred royalty
obligation
$103,409K
Total current
liabilities
$104,267K
Common stock, 0.001 par
value 120,000,000...
$67K
Deferred royalty
obligation, current
$5,556K
Lease liability
$624K
Accrued expenses and
other current...
$84,456K
Accounts payable
$13,631K
Subscribe for Financial Insights
RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. (RYTM)